Stage II Breast Cancer Terminated Phase 2 Trials for Anastrozole (DB01217)

IndicationStatusPhase
DBCOND0029484 (Stage II Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01394211Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast CancerTreatment
NCT01234532Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by SurgeryTreatment
NCT01368263Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast CancerTreatment